Adaptive Biotechnologies Corporation ADPT
29.43
(0.14)
(0.47%)
as of 25 Sep
- Market cap
- $4.7B
- P/E
- 0.0×
Follow ADPT
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
8.90 | 4.93 | 4.04 | 6.00 | 25.52 | 78.86 | 24.33 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.66 | 2.20 | 2.20 |
P/Operating CF |
1,199.01 | (70.66) | (25.57) | (37.03) | (73.17) | (194.73) | (77.24) | 1.87 | 1.87 |
P/B ratio |
10.95 | 4.36 | 2.23 | 2.40 | 6.52 | 10.44 | 3.62 | 0.00 | 0.00 |
Price to Tangible BV |
23.62 | 11.02 | 3.74 | 3.29 | 8.26 | 12.64 | 4.70 | 0.00 | 0.00 |
EV/Sales |
8.87 | 4.91 | 3.29 | 4.52 | 23.92 | 72.93 | 17.98 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(53.40) | (9.23) | (3.59) | (4.55) | (19.16) | (47.93) | 7.44 | 1.44 | 1.44 |
EV/FCF |
(50.17) | (8.89) | (3.36) | (4.18) | (14.51) | (42.58) | 7.87 | 1.50 | 1.50 |
Quick Ratio |
3.08 | 2.69 | 4.37 | 4.90 | 3.26 | 6.64 | 7.53 | 7.45 | 9.41 |
Current Ratio |
3.34 | 2.89 | 4.66 | 5.12 | 3.54 | 6.91 | 7.82 | 7.93 | 9.77 |
Net Debt/EBITDA |
5.43 | 1.47 | 1.62 | 1.54 | 1.31 | 4.07 | 7.20 | (8.81) | (9.65) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 26.15% | 11.59% | 9.32% | 4.01% | 168.63% | 155.04% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.48 | 0.18 | 0.14 | 0.06 | 1.85 | 1.67 |
Asset Turnover |
0.53 | 0.30 | 0.22 | 0.21 | 0.15 | 0.10 | 0.14 | 0.16 | 0.11 |
Operating CF/Net income |
0.77 | 0.60 | 0.69 | 0.92 | 0.93 | 1.02 | (2.95) | 0.70 | 0.82 |
Capex/Depreciation |
(0.19) | (22.44) | (33.74) | (13.62) | (2.91) | (2.03) | (3.37) | (1.32) | (0.37) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (27.84%) | (62.45%) | (58.33%) | (37.48%) | (30.77%) | (22.25%) | (44.46%) | 19.20% | 17.68% | |
| (11.31%) | (26.57%) | (29.68%) | (22.49%) | (20.32%) | (14.42%) | (11.18%) | (13.33%) | (12.29%) | |
ROIC |
0.00% | 0.00% | 0.00% | (65.88%) | (36.48%) | (60.07%) | (159.18%) | (4.45%) | (3.93%) |
Return on Tangible Assets |
(24.35%) | (68.07%) | (57.70%) | (37.36%) | (55.39%) | (22.11%) | (11.70%) | (26.18%) | (21.54%) |
Average Days of Receivables |
66.37 | 85.11 | 81.39 | 78.90 | 41.17 | 37.27 | 54.39 | 31.52 | 52.99 |
Research and Development Expense of Revenue |
33.85% | 57.53% | 71.72% | 76.50% | 92.22% | 117.98% | 83.11% | 70.35% | 83.22% |
Selling, General and Administrative Expense of Revenue |
60.39% | 88.05% | 101.31% | 99.36% | 110.12% | 112.72% | 80.86% | 80.66% | 85.09% |
Intangible Assets out of Total Assets |
0.24 | 0.23 | 0.19 | 0.15 | 0.14 | 0.12 | 0.14 | 0.40 | 0.37 |
Share Based Compensation of Revenue |
18.59% | 29.96% | 36.94% | 29.94% | 28.02% | 25.17% | 15.43% | 20.03% | 18.23% |
Graham Net Nets |
0.01 | (0.06) | 0.08 | 0.15 | 0.02 | 0.05 | 0.13 | 0.35 | 0.35 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2.46%) | (18.17%) | (32.70%) | (18.08%) | (5.24%) | (1.88%) | (9.82%) | (1.81%) | (1.81%) |
Free Cash Flow Yield |
(1.99%) | (11.20%) | (24.25%) | (18.02%) | (6.46%) | (2.17%) | 9.38% | 45.43% | 45.43% |
Revenue per Share |
1.83 | 1.22 | 1.18 | 1.30 | 1.10 | 0.75 | 1.23 | 4.41 | 3.15 |
Operating CF per Share |
(0.30) | (0.65) | (1.08) | (1.29) | (1.37) | (1.14) | 2.97 | (2.55) | (2.86) |
Capex per Share |
(0.02) | (1.69) | (3.05) | (2.07) | (0.44) | (0.14) | (0.16) | (0.50) | (0.19) |
Free Cash Flow per Share |
(0.32) | (2.33) | (4.13) | (3.36) | (1.81) | (1.28) | 2.81 | (3.05) | (3.05) |
Cash per Share |
1.50 | 1.51 | 2.40 | 3.50 | 2.52 | 5.25 | 8.34 | 13.07 | 15.75 |
Shareholders Equity per Share |
1.48 | 1.38 | 2.14 | 3.26 | 4.30 | 5.66 | 8.26 | 23.97 | 27.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.48 | 1.38 | 2.14 | 3.26 | 4.30 | 5.66 | 8.26 | 23.97 | 27.61 |
Free Cash Flow |
(48.94) | (343.13) | (596.58) | (479.07) | (254.47) | (168.49) | 194.20 | (38.56) | (37.16) |
Working Capital |
210.27 | 185.70 | 322.17 | 452.36 | 288.94 | 621.72 | 534.38 | 157.92 | 184.24 |
Capital Expenditures |
(2.96) | (247.92) | (440.25) | (295.13) | (61.75) | (18.80) | (11.20) | (6.30) | (2.30) |
Net Current Asset Value |
12.45 | (53.14) | 57.33 | 169.63 | 83.51 | 353.77 | 271.43 | 150.78 | 179.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 1.39 | 2.59 | 1.59 | 0.40 | 0.19 | 0.13 | 0.11 | 0.06 |
Net Profit Margin |
(21.48%) | (89.12%) | (132.29%) | (108.03%) | (134.30%) | (148.63%) | (81.78%) | (83.26%) | (111.05%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.45 | 0.23 | 0.19 | 0.26 | 0.25 | 0.23 | 0.06 | 0.25 | 0.44 |
Cash ROIC |
(17.72%) | (33.86%) | (34.30%) | (22.54%) | (26.12%) | (12.33%) | 12.25% | (4.99%) | (4.47%) |
Accounts Receivable Turnover |
6.01 | 4.49 | 4.36 | 6.45 | 11.24 | 8.66 | 9.73 | 10.72 | 6.99 |
Accounts Payable Turnover |
10.39 | 9.62 | 9.56 | 10.17 | 15.07 | 5.86 | 7.13 | 10.47 | 7.84 |
Inventory Turnover |
7.82 | 6.30 | 5.23 | 3.44 | 2.96 | 1.95 | 2.63 | 3.11 | 2.41 |
Average Days of Payables |
33.08 | 36.79 | 37.29 | 50.95 | 24.48 | 52.44 | 72.97 | 33.27 | 45.72 |
Days of Inventory on Hand |
50.23 | 42.74 | 69.80 | 91.10 | 142.61 | 227.83 | 148.61 | 145.46 | 111.55 |
Average Receivables |
46.05 | 39.85 | 39.01 | 28.73 | 13.73 | 11.36 | 8.74 | 5.19 | 5.50 |
Average Payables |
6.87 | 7.49 | 7.90 | 5.70 | 3.27 | 3.85 | 3.12 | 1.88 | 2.00 |
Average Inventory |
9.13 | 11.44 | 14.45 | 16.86 | 16.66 | 11.57 | 8.45 | 6.32 | 6.50 |
Average Assets |
526.06 | 600.26 | 758.88 | 889.98 | 1,019.88 | 1,014.36 | 622.50 | 347.59 | 347.50 |
Average Common Equity |
213.74 | 255.38 | 386.19 | 534.10 | 673.68 | 657.15 | 156.46 | (241.36) | (241.50) |
Columns are period end dates